P3.02a-003 ALK and ROS1 Rearrangements, Coexistence and Treatment in EGFR-Wild Type Lung Adenocarcinoma - A Multicenter Study of 732 Cases

Zhengbo Song; Yuhui Zheng; Yiping Zhang

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >P3.02a-003 ALK and ROS1 Rearrangements, Coexistence and Treatment in EGFR-Wild Type Lung Adenocarcinoma - A Multicenter Study of 732 Cases

【24h】

P3.02a-003 ALK and ROS1 Rearrangements, Coexistence and Treatment in EGFR-Wild Type Lung Adenocarcinoma - A Multicenter Study of 732 Cases

机译：P3.02A-003 ALK和ROS1重排，共存和治疗，在EGFR-野生型肺腺癌中 - 732例多中心研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共2页
作者
Zhengbo Song; Yuhui Zheng; Yiping Zhang;
展开▼
作者单位

Medical Oncology Zhejiang Cancer Hospital;

Department of Pathology fujian Medical University union Hospital;

Zhejiang Cancer Hospital;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. P3.02a-003 ALK and ROS1 Rearrangements, Coexistence and Treatment in EGFR-Wild Type Lung Adenocarcinoma - A Multicenter Study of 732 Cases [J] . Zhengbo Song, Yuhui Zheng, Yiping Zhang Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P3.02A-003 ALK和ROS1重排，共存和治疗，在EGFR-野生型肺腺癌中 - 732例多中心研究
2. P3.02a-003 ALK and ROS1 Rearrangements, Coexistence and Treatment in EGFR-Wild Type Lung Adenocarcinoma - A Multicenter Study of 732 Cases [J] . Zhengbo Song, Yuhui Zheng, Yiping Zhang Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P3.02A-003 ALK和ROS1重排，共存和治疗，在EGFR-野生型肺腺癌中 - 732例多中心研究
3. ALK and ROS1 rearrangements, coexistence and treatment in epidermal growth factor receptor-wild type lung adenocarcinoma: a multicenter study of 732 cases [J] . Zhengbo Song, Yuhui Zheng, Xuzhou Wang, Journal of Thoracic Disease . 2017,第10期

机译：表皮生长因子受体野生型肺腺癌的ALK和ROS1重排，共存和治疗：732例多中心研究
4. High throughput multiplexed phosphoproteomics identifies drivers of resistance to ALK inhibitor treatment in lung cancer [C] . Amanda L. Edwards, Luc Friboulet, Rosa Frias, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：高通量复用磷蛋白酶鉴定肺癌抗华抗抑制剂治疗的驱动因素
5. Localization-based Signaling Pathway Dependence of ROS1 Fusions and a Novel Role for Ras in EML4-ALK-Driven Lung Cancer [D] . Neel, Dana Sarabeth. 2017

机译：ROS1融合的基于本地化的信号通路依赖性和在EML4-ALK驱动的肺癌中Ras的新作用。
6. ALK and ROS1 rearrangements coexistence and treatment in epidermal growth factor receptor-wild type lung adenocarcinoma: a multicenter study of 732 cases [O] . Zhengbo Song, Yuhui Zheng, Xuzhou Wang, 2017

机译：表皮生长因子受体野生型肺腺癌的ALK和ROS1重排共存和治疗：732例多中心研究
7. ALK and ROS1 rearrangements, coexistence and treatment in epidermal growth factor receptor-wild type lung adenocarcinoma: a multicenter study of 732 cases [O] . Zhengbo Song, Yuhui Zheng, Xuzhou Wang, 2017

机译：表皮生长因子受体 - 野生型肺腺癌中的ALK和ROS1重排，共存和治疗：732例的多中心研究

P3.02a-003 ALK and ROS1 Rearrangements, Coexistence and Treatment in EGFR-Wild Type Lung Adenocarcinoma - A Multicenter Study of 732 Cases

著录项

相似文献

相关主题

期刊订阅